Beam Therapeutics Cash from Financing (TTM) Trends

Beam Therapeutics Inc (BEAM)

23.92 -0.39 (-1.60%) USD | NASDAQ | Apr 19, 16:00

23.90 -0.02 (-0.08%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	276.45M
September 30, 2023	274.75M
June 30, 2023	239.53M
March 31, 2023	154.33M
December 31, 2022	111.59M
September 30, 2022	101.12M
June 30, 2022	420.44M
March 31, 2022	558.54M
December 31, 2021	756.14M

Date	Value
September 30, 2021	864.59M
June 30, 2021	543.80M
March 31, 2021	382.58M
December 31, 2020	322.32M
September 30, 2020	193.03M
June 30, 2020	195.63M
March 31, 2020	196.38M
December 31, 2019	41.28M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

41.28M

Minimum

Dec 2019

864.59M

Maximum

Sep 2021

331.32M

Average

274.75M

Median

Sep 2023

Cash from Financing (TTM) Benchmarks